Sponsored by:

The 3 Best Biotech ETF Investments

Get direct exposure to the biotech sector with these funds

    View All  
The 3 Best Biotech ETF Investments

Market Vectors Biotech ETF (BBH)

MarketVectors185 The 3 Best Biotech ETF InvestmentsTotal Assets Under Management: $432 million
Expense Ratio: 0.35%

If you’re looking for a big, concentrated biotech ETF investment, check out the Market Vectors Biotech ETF (BBH), which aims to track the largest, most liquid biotech stocks in the industry.

This biotech ETF only has 26 holdings currently, and its top 10 holdings make up 68% of the fund. Biotech stocks Gilead Sciences and Amgen take up 13.8% and 11.7% spots in the Market Vector Biotech ETF, and Celgene and Biogen are heavily held. Toss in Regeneron Pharmaceuticals (REGN) and Alexion Pharmaceuticals (ALXN), and you have more than half the fund’s weighting in just six stocks!

Another thing to note: The Market Vector Biotech ETF is relatively new, having launched in late 2011, but has improved more than 60% since inception. As of now, it has roughly $435 million in assets under management.

BBH also boasts an appealing expense ratio of just 0.35%.

As of this writing, Alyssa Oursler was long IBB.


Article printed from InvestorPlace Media, http://investorplace.com/2013/10/3-best-biotech-etf-investments/.

©2014 InvestorPlace Media, LLC

Comments are currently unavailable. Please check back soon.